Cytotoxic Agents in the Minor Alkaloid Groups of the Amaryllidaceae^{[ # ]}

Abstract

Over 600 alkaloids have to date been identified in the plant family Amaryllidaceae. These have been arranged into as many as 15 different groups based on their characteristic structural features. The vast majority of studies on the biological properties of Amaryllidaceae alkaloids have probed their anticancer potential. While most efforts have focused on the major alkaloid groups, the volume and diversity afforded by the minor alkaloid groups have promoted their usefulness as targets for cancer cell line screening purposes. This survey is an in-depth review of such activities described for around 90 representatives from 10 minor alkaloid groups of the Amaryllidaceae. These have been evaluated against over 60 cell lines categorized into 18 different types of cancer. The montanine and cripowellin groups were identified as the most potent, with some in the latter demonstrating low nanomolar level antiproliferative activities. Despite their challenging molecular architectures, the minor alkaloid groups have allowed for facile adjustments to be made to their structures, thereby altering the size, geometry, and electronics of the targets available for structure-activity relationship studies. Nevertheless, it was seen with a regular frequency that the parent alkaloids were better cytotoxic agents than the corresponding semisynthetic derivatives. There has also been significant interest in how the minor alkaloid groups manifest their effects in cancer cells. Among the various targets and pathways in which they were seen to mediate, their ability to induce apoptosis in cancer cells is most appealing.

Key words

Amaryllidaceae - antiproliferative - cancer - cytotoxic - isoquinoline alkaloid

^# Dedicated to Professor Arnold Vlietinck on the occasion of his 80th birthday.

Publication History

Received: 12 December 2020

Accepted after revision: 16 February 2021

Article published online:
11 March 2021

• References

• 1 World Health Organization. WHO Report on Cancer. Geneva: WHO Press; 2020: 1-160
• 2 Cragg GM, Pezzuto JM. Natural products as a vital source for the discovery of cancer chemotherapeutic and chemopreventive agents. Med Princ Pract 2016; 25: 41-59
• 3 Bastida J, Lavilla R, Viladomat F. Chemical and biological Aspects of Narcissus Alkaloids. In: Cordell GA. ed. The Alkaloids. Amsterdam: Elsevier; 2006: 87-179
• 4 Nair JJ, van Staden J. Pharmacological and toxicological insights to the South African Amaryllidaceae. Food Chem Toxicol 2013; 62: 262-275
• 5 Kornienko A, Evidente A. Chemistry, biology and medicinal potential of narciclasine and its congeners. Chem Rev 2008; 108: 1982-2014
• 6 Ceriotti G. Narciclasine: an antimitotic substance from Narcisssus bulbs. Nature 1967; 213: 595-596
• 7 Pettit GR, Gaddamidi V, Cragg GM. Antineoplastic agents. 105. Zephyranthes grandiflora . J Nat Prod 1984; 47: 1018-1020
• 8 Nair JJ, van Staden J, Bastida J. Cytotoxic Alkaloid Constituents of the Amaryllidaceae. In: Rahman A-U. ed. Studies in natural Products Chemistry. Oxford: Elsevier; 2016: 107-156
• 9 Jin Z, Yao G. Amaryllidaceae and Sceletium alkaloids. Nat Prod Rep 2019; 36: 1462-1488
• 10 Kaya GI, Sarıkaya B, Onur MA, Somer NU, Viladomat F, Codina C, Bastida J, Lauinger IL, Kaiser M, Tasdemir D. Antiprotozoal alkaloids from Galanthus trojanus . Phytochem Lett 2011; 4: 301-305
• 11 NʼTamon AD, Okpekon AT, Bony NF, Bernadat G, Gallard JF, Kouamé T, Séon-Méniel B, Leblanc K, Rharrabti S, Mouray E, Grellier P, Ake M, Amin NC, Champy P, Beniddir MA, Le Pogam P. Streamlined targeting of Amaryllidaceae alkaloids from the bulbs of Crinum scillifolium using spectrometric and taxonomically-informed scoring metabolite annotations. Phytochemistry 2020; 179: 112485/1-112485/8
• 12 Hulcova D, Breiterova K, Zemanova L, Siatka T, Safratova M, Vaneckova N, Hostalkova A, Wsol V, Cahlikova L. AKR1C3 inhibitory potency of naturally-occurring Amaryllidaceae alkaloids of different structural types. Nat Prod Commun 2017; 12: 245-246
• 13 Hulcova D, Breiterova K, Siatka T, Klimova K, Davani L, Safratova M, Hostalkova A, de Simone A, Andrisano V, Cahlikova L. Amaryllidaceae alkaloids as potential glycogen synthase kinase-3β inhibitors. Molecules 2018; 23: 719/1-719/9
• 14 Shawky E. In-silico profiling of the biological activities of Amaryllidaceae alkaloids. J Pharm Pharmacol 2017; 69: 1592-1605
• 15 Zupko I, Rethey B, Hohmann J, Molnar J, Ocsovski I, Falkay G. Antitumor activity of alkaloids derived from Amaryllidaceae species. In Vivo 2009; 23: 41-48
• 16 Ibrahim SRM, Mohamed GA, Shaala LA, Youssef DTA, El Sayed KA. New alkaloids from Pancratium maritimum . Planta Med 2013; 79: 1480-1484
• 17 Luo Z, Wang F, Zhang J, Li X, Zhang M, Hao X, Xue Y, Li Y, Horgen FD, Yao G, Zhang Y. Cytotoxic alkaloids from the whole plants of Zephyranthes candida . J Nat Prod 2012; 75: 2113-2120
• 18 Ang S, Liu XM, Huang XJ, Zhang DM, Zhang W, Wang L, Ye WC. Four new Amaryllidaceae alkaloids from Lycoris radiata and their cytotoxicity. Planta Med 2015; 81: 1712-1718
• 19 Zhu YY, Li X, Yu HY, Xiong YF, Zhang P, Pi HF, Ruan HL. Alkaloids from the bulbs of Lycoris longituba and their neuroprotective and acetylcholinesterase inhibitory activities. Arch Pharm Res 2015; 38: 604-613
• 20 Morikawa T, Ninomiya K, Kuramoto H, Kamei I, Yoshikawa M, Muraoka O. Phenylethanoid and phenylpropanoid glycosides with melanogenesis inhibitory activity from the flowers of Narcissus tazetta var. chinensis . J Nat Med 2016; 70: 89-101
• 21 Cole ER, de Andrade JP, Filho JFA, Schmitt EFP, Alves-Araujo A, Bastida J, Endringer DC, de Souza Borges W, Lacerda V. Cytotoxic and genotoxic activities of alkaloids from the bulbs of Griffinia gardneriana and Habranthus itaobinus (Amaryllidaceae). Anticancer Agents Med Chem 2019; 19: 707-717
• 22 Weniger B, Italiano L, Beck JP, Bastida J, Bergoñon S, Codina C, Lobstein A, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids. Planta Med 1995; 61: 77-79
• 23 Hao B, Shen SF, Zhao QJ. Cytotoxic and antimalarial alkaloids from the bulbs of Lycoris radiata . Molecules 2013; 18: 2458-2468
• 24 Song JH, Zhang L, Song Y. Alkaloids from Lycoris aurea and their cytotoxicities against the head and neck squamous cell carcinoma. Fitoterapia 2014; 95: 121-126
• 25 Ka S, Masi M, Merindol N, Di Lecce R, Plourde MB, Seck M, Gorecki M, Pescitelli G, Desgagne-Penix I, Evidente A. Gigantelline, gigantellinine and gigancrinine, cherylline- and crinine-type alkaloids isolated from Crinum jagus with anti-acetylcholinesterase activity. Phytochemistry 2020; 175: 112390/1-112390/9
• 26 Heinrich M. Galanthamine from Galanthus and other Amaryllidaceae – Chemistry and Biology based on traditional Use. In: Cordell GA. ed. The Alkaloids. Chennai: Academic Press; 2010: 157-165
• 27 Jimenez A, Santos A, Alonso G, Vazquez D. Inhibitors of protein synthesis in eukaryotic cells. Comparative effects of some Amaryllidaceae alkaloids. Biochim Biophys Acta 1976; 425: 342-348
• 28 Furusawa E, Irie H, Combs D, Wildman WC. Therapeutic activity of pretazettine on Rauscher leukemia: comparison with the related Amaryllidaceae alkaloids. Chemotherapy 1980; 26: 36-45
• 29 Nair JJ, Rárová L, Strnad M, Bastida J, van Staden J. Apoptosis-inducing effects of distichamine and narciprimine, rare alkaloids of the plant family Amaryllidaceae. Bioorg Med Chem Lett 2012; 22: 6195-6199
• 30 Ezoulin MJM, Dong CZ, Liu Z, Li J, Chen HZ, Heymans F, Lelievre L, Ombetta JE, Massicot F. Study of PMS777, a new type of acetylcholinesterase inhibitor, in human HepG2 cells. Comparison with tacrine and galanthamine on oxidative stress and mitochondrial impairment. Toxicol In Vitro 2006; 20: 824-831
• 31 Breiterova K, Koutova D, Marikova J, Havelek R, Kunes J, Majorosova M, Opletal L, Hostalkova A, Jenco J, Rezacova M, Cahlikova L. Amaryllidaceae alkaloids of different structural types from Narcissus L. cv. Professor Einstein and their cytotoxic activity. Plants 2020; 9: 137/1-137/12
• 32 Osorio EJ, Berkov S, Brun R, Codina C, Viladomat F, Cabezas F, Bastida J. In vitro antiprotozoal activity of alkaloids from Phaedranassa dubia (Amaryllidaceae). Phytochem Lett 2010; 3: 161-163
• 33 Doskocil I, Hostalkova A, Safratova M, Benesova N, Havlik J, Havelek R, Kunes J, Kralovec K, Chlebek J, Cahlikova L. Cytotoxic activities of Amaryllidaceae alkaloids against gastrointestinal cancer cells. Phytochem Lett 2015; 13: 394-398
• 34 Havelek R, Muthna D, Tomsik P, Kralovec K, Seifrtova M, Cahlikova L, Hostalkova A, Safratova M, Perwein M, Cermakova E, Rezacova M. Anticancer potential of Amaryllidaceae alkaloids evaluated by screening with a panel of human cells, real-time cellular analysis and Ehrlich tumor-bearing mice. Chem Biol Interact 2017; 275: 121-132
• 35 Carvalho KR, Silva AB, Torres MCM, Pinto FCL, Guimaraes LA, Rocha DD, Silveira ER, Costa-Lotufo LV, Braz-Filho R, Pessoa ODL. Cytotoxic alkaloids from Hippeastrum solandriflorum Lindl. J Braz Chem Soc 2015; 26: 1976-1980
• 36 Jitsuno M, Yokosuka A, Hashimoto K, Amano O, Sakagami H, Mimaki Y. Chemical constituents of Lycoris albiflora and their cytotoxic activities. Nat Prod Commun 2011; 6: 187-192
• 37 Jin A, Li X, Zhu YY, Yu HY, Pi HF, Zhang P, Ruan HL. Four new compounds from the bulbs of Lycoris aurea with neuroprotective effects against CoCl₂ and H₂O₂-induced SH-SY5Y cell injuries. Arch Pharm Res 2014; 37: 315-323
• 38 Castillo WO, Aristizabal-Pachon AF, de Lima Montaldi AP, Sakamoto-Hojo ET, Takahashi CS. Galanthamine decreases genotoxicity and cell death induced by β-amyloid peptide in SH-SY5Y cell line. Neurotoxicology 2016; 57: 291-297
• 39 Trujillo-Chacon LM, Alarcon-Enos JE, Cespedes-Acuna CL, Bustamante L, Baeza M, Lopez MG, Fernandez-Mendivil C, Cabezas F, Pastene-Navarrete ER. Neuroprotective activity of isoquinoline alkaloids from of Chilean Amaryllidaceae plants against oxidative stress-induced cytotoxicity on human neuroblastoma SH-SY5Y cells and mouse hippocampal slice culture. Food Chem Toxicol 2019; 132: 110665/1-110665/11
• 40 Labrana J, Machocho AK, Kricsfalusy V, Brun R, Codina C, Viladomat F, Bastida J. Alkaloids from Narcissus angustifolius subsp. transcarpathicus (Amaryllidaceae). Phytochemistry 2002; 60: 847-852
• 41 Cedron JC, Ravelo AG, Leon LG, Padron JM, Estevez-Braun A. Antiproliferative and structure activity relationships of Amaryllidaceae alkaloids. Molecules 2015; 20: 13854-13863
• 42 Govindaraju K, Ingels A, Hasan MN, Sun D, Mathieu V, Masi M, Evidente A, Kornienko A. Synthetic analogues of the montanine-type alkaloids with activity against apoptosis-resistant cancer cells. Bioorg Med Chem Lett 2018; 28: 589-593
• 43 Silva AFS, de Andrade JP, Machado KRB, Rocha AB, Apel MA, Sobral MEG, Henriques AT, Zuanazzi JAS. Screening for cytotoxic activity of extracts and isolated alkaloids from bulbs of Hippeastrum vittatum . Phytomedicine 2008; 15: 882-885
• 44 Al Shammari L, Al Mamun A, Koutová D, Majorošová M, Hulcová D, Šafratová M, Breiterová K, Maříková J, Havelek R, Cahlíková L. Alkaloid profiling of Hippeastrum cultivars by GC-MS, isolation of Amaryllidaceae alkaloids and evaluation of their cytotoxicity. Rec Nat Prod 2020; 14: 154-159
• 45 Wu WM, Zhu YY, Li HR, Yu HY, Zhang P, Pi HF, Ruan HL. Two new alkaloids from the bulbs of Lycoris sprengeri . J Asian Nat Prod Res 2014; 16: 192-199
• 46 Masi M, van Slambrouck S, Gunawardana S, van Rensburg MJ, James PC, Mochel JG, Heliso PS, Albalawi AS, Cimmino A, van Otterlo WAL, Kornienko A, Green IR, Evidente A. Alkaloids isolated from Haemanthus humilis Jacq., an indigenous South African Amaryllidaceae: anticancer activity of coccinine and montanine. S Afr J Bot 2019; 126: 277-281
• 47 Hulcova D, Marikova J, Korabecny J, Hostalkova A, Jun D, Kunes J, Chlebek J, Opletal L, de Simone A, Novakova L, Andrisano V, Ruzicka A, Cahlikova L. Amaryllidaceae alkaloids from Narcissus pseudonarcissus L. cv. Dutch Master as potential drugs in treatment of Alzheimerʼs disease. Phytochemistry 2019; 165: 112055/1-112055/9
• 48 Ali AA, Hambloch H, Frahm AW. Alkaloids of Crinum augustum. Part 4. Relative configuration of the alkaloid augustamine. Phytochemistry 1983; 22: 283-287
• 49 Machocho AK, Bastida J, Codina C, Viladomat F, Brun R, Chhabra SC. Augustamine-type alkaloids from Crinum kirkii . Phytochemistry 2004; 65: 3143-3149
• 50 Hanh TTH, Anh DH, Huong PTT, Nguyen VT, Nguyen QT, Cuong TV, Nguyen TM, Nguyen TC, Nguyen XC, Nguyen HN, Minh CV. Crinane, augustamine, and β-carboline alkaloids from Crinum latifolium . Phytochem Lett 2018; 24: 27-30
• 51 Tallini LR, Torras-Claveria L, de Souza Borges W, Kaiser M, Viladomat F, Zuanazzi JAS, Bastida J. N-oxide alkaloids from Crinum amabile (Amaryllidaceae). Molecules 2018; 23: 1277/1-1277/11
• 52 Hafiz AMA, Ramadan MA, Jung ML, Beck JP, Anton R. Cytotoxic activity of Amaryllidaceae alkaloids from Crinum augustum and Crinum bulbispermum . Planta Med 1991; 57: 437-439
• 53 Velten R, Erdelen C, Gehling M, Gohrt A, Gondol D, Lenz J, Lockhoff O, Wachendorff U, Wendisch D. Cripowellin A and B, a novel type of Amaryllidaceae alkaloid from Crinum powellii . Tet Lett 1998; 39: 1737-1740
• 54 Presley CC, Krai P, Dalal S, Su Q, Cassera M, Goetz M, Kingston DGI. New potently bioactive alkaloids from Crinum erubescens . Bioorg Med Chem 2016; 24: 5418-5422
• 55 Chen MX, Huo JM, Hu J, Xu ZP, Zhang X. Amaryllidaceae alkaloids from Crinum latifolium with cytotoxic, antimicrobial, antioxidant and anti-inflammatory activities. Fitoterapia 2018; 130: 48-53
• 56 Tram NTM, Titorenkova TV, Bankova VS, Handjieva NV, Popov SS. Crinum L. (Amaryllidaceae); a review. Fitoterapia 2002; 73: 183-208
• 57 Zhan G, Qu X, Liu J, Tong Q, Zhou J, Sun B, Yao G. Zephycandidine A, the first naturally occurring imidazo[1,2-f. phenanthridine alkaloid from Zephyranthes candida, exhibits significant anti-tumor and antiacetylcholinesterase activities. Sci Rep 2016; 6: 33990/1-33990/9
• 58 Nair JJ, van Staden J. Cytotoxic tazettine alkaloids of the plant family Amaryllidaceae. S Afr J Bot 2021; 136: 147-156
• 59 Nair JJ, van Staden J. The plant family Amaryllidaceae as a source of cytotoxic homolycorine alkaloid principles. S Afr J Bot 2021; 136: 157-174
• 60 Schmeda-Hirschmann G, Astudillo L, Bastida J, Viladomat F, Codina C. DNA binding activity of Amaryllidaceae alkaloids. J Chil Chem Soc 2000; 45: 515-518
• 61 Hohmann J, Forgo P, Molnár J, Wolfard K, Molnár A, Thalhammer T, Mathé I, Sharples D. Antiproliferative Amaryllidaceae alkaloids isolated from the bulbs of Sprekelia formosissima and Hymenocallis x festalis . Planta Med 2002; 68: 454-457
• 62 Ingrassia L, Lefranc F, Dewelle J, Pottier L, Mathieu V, Spiegl-Kreinecker S, Sauvage S, El Yazidi M, Dehoux M, Berger W, van Quaquebeke E, Kiss R. Structure-activity relationship analysis of novel derivatives of narciclasine (an Amaryllidaceae isocarbostyril derivative) as potential anticancer agents. J Med Chem 2009; 52: 1100-1114
• 63 Lefranc F, Sauvage S, van Goietsenoven G, Mégalizzi V, Lamoral-Theys D, Debeir O, Spiegl-Kreinecker S, Berger W, Mathieu V, Decaestecker C, Kiss R. Narciclasine, a plant growth modulator, activates Rho and stress fibers in glioblastoma cells. Mol Cancer Ther 2009; 8: 1739-1750
• 64 Antonicek HP, Velten R, Jeschke P. Cripowellins and synthetic derivatives thereof used as medicaments. European Patent WO2006136309A1, 2006
• 65 McNulty J, Nair JJ, Singh M, Crankshaw DJ, Holloway AC, Bastida J. Selective cytochrome P450 3A4 inhibitory activity of Amaryllidaceae alkaloids. Bioorg Med Chem Lett 2009; 19: 3233-3237
• 66 Rendic S, Di Carlo FJ. Human cytochrome P450 enzymes: a status report summarizing their reactions, substrates, inducers and inhibitors. Drug Metab Rev 1997; 29: 413-580
• 67 Sharom FJ. The P-glycoprotein multidrug transporter. Essays Biochem 2011; 50: 161-178
• 68 Stafford GI, Birer C, Brodin B, Christensen SB, Eriksson AH, Jäger AK, Rønsted N. Serotonin transporter protein (SERT) and P-glycoprotein (P-gp) binding activity of montanine and coccinine from three species of Haemanthus L. (Amaryllidaceae). S Afr J Bot 2013; 88: 101-106
• 69 Abdel-Halim OB, Morikawa T, Ando S, Matsuda H, Yoshikawa M. New crinine-type alkaloids with inhibitory effect on induction of inducible nitric oxide synthase from Crinum yemense . J Nat Prod 2004; 67: 1119-1124
• 70 Xu W, Liu LZ, Loizidou M, Ahmed M, Charles IG. The role of nitric oxide in cancer. Cell Res 2002; 12: 311-320
• 71 Champoux JJ. DNA topoisomerases: structure, function and mechanism. Annu Rev Biochem 2001; 70: 369-413
• 72 Sarıkaya BB, Zencir S, Somer NU, Kaya GI, Onur MA, Bastida J, Berenyi A, Zupko I, Topcu Z. The effects of arolycoricidine and narciprimine on tumor cell killing and topoisomerase activity. Rec Nat Prod 2012; 6: 381-385
• 73 Nino J, Hincapié GM, Correa YM, Mosquera OM. Alkaloids of Crinum x powellii “Album” (Amaryllidaceae) and their topoisomerase inhibitory activity. Z Naturforsch 2007; 62c: 223-226
• 74 Evidente A, Kireev AS, Jenkins AR, Romero AE, Steelant WFA, van Slambrouck S, Kornienko A. Biological evaluation of structurally diverse Amaryllidaceae alkaloids and their synthetic derivatives: discovery of novel leads for anticancer drug design. Planta Med 2009; 75: 501-507
• 75 Stock AM, Troost G, Niggemann B, Zänker KS, Entschladen F. Targets for anti-metastatic drug development. Curr Pharm Des 2013; 19: 5127-5134
• 76 Kovalevich J, Langford D. Considerations for the use of SH-SY5Y neuroblastoma cells in neurobiology. Methods Mol Biol 2013; 1078: 9-21
• 77 Coussens LM, Werb Z. Inflammation and cancer. Nature 2002; 420: 860-867
• 78 Park JB. Synthesis and characterization of norbelladine, a precursor of Amaryllidaceae alkaloid, as an anti-inflammatory/anti-COX compound. Bioorg Med Chem Lett 2014; 24: 5381-5384
• 79 Nair JJ, van Staden J, Bastida J. Apoptosis-inducing effects of Amaryllidaceae alkaloids. Curr Med Chem 2016; 23: 161-185
• 80 Wang S, Yin J, Chen D, Nie F, Song X, Fei C, Miao H, Jing C, Ma W, Wang L, Xie S, Li C, Zeng R, Pan W, Hao X, Li L. Small-molecule modulation of Wnt signaling via modulating the Axin-LRP5/6 interaction. Nat Chem Biol 2013; 9: 579-585
• 81 Clevers H, Nusse R. Wnt/β-catenin signaling and disease. Cell 2012; 149: 1192-1205
• 82 Cohen GM. Caspases: the executioners of apoptosis. Biochem J 1997; 326: 1-16
• 83 Van Goietsenoven G, Andolfi A, Lallemand B, Cimmino A, Lamoral-Theys D, Gras T, Abou-Donia A, Dubois J, Lefranc F, Mathieu V, Kornienko A, Kiss R, Evidente A. Amaryllidaceae alkaloids belonging to different structural subgroups display activity against apoptosis-resistant cancer cells. J Nat Prod 2010; 73: 1223-1227
• 84 Manning G, Whyte DB, Martinez R, Hunter T, Sudarsanam S. The protein kinase complement of the human genome. Science 2002; 298: 1912-1934
• 85 Luo J. Glycogen synthase kinase 3b (GSK3b) in tumorigenesis and cancer chemotherapy. Cancer Lett 2009; 273: 194-200
• 86 Bolanos-Garcia VM. Aurora kinases. Int J Biochem Cell Biol 2005; 37: 1572-1577
• 87 Milazzo G, Mercatelli D, Di Muzio G, Triboli L, De Rosa P, Perini G, Giorgi FM. Histone deacetylases (HDACs): evolution, specificity, role in transcriptional complexes, and pharmacological actionability. Genes (Basel) 2020; 11: 556/1-556/49
• 88 Li L, Dai HJ, Ye M, Wang SL, Xiao XJ, Zheng J, Chen HY, Luo YH, Liu J. Lycorine induces cell cycle arrest in the G₀/G₁ phase in K562 cells via HDAC inhibition. Cancer Cell Int 2012; 12: 49-54
• 89 Holmes DIR, Zachary I. The vascular endothelial growth factor (VEGF) family: angiogenic factors in health and disease. Genome Biol 2005; 6: 209/1-209/10
• 90 Penning TM, Byrns MC. Steroid hormone transforming aldo-keto reductases and cancer. Ann N Y Acad Sci 2009; 1155: 33-42
• 91 Stahl SM. Mechanism of action of serotonin selective reuptake inhibitors: serotonin receptors and pathways mediate therapeutic effects and side effects. J Affect Disord 1998; 51: 215-235
• 92 Sarrouilhe D, Mesnil M. Serotonin and human cancer: a critical view. Biochimie 2019; 161: 46-50
• 93 Shinka T, Onodera D, Tanaka T, Miyazaki T, Moriuchi T, Fukumoto T. Serotonin synthesis and metabolism-related molecules in a human prostate cancer cell line. Oncol Lett 2011; 2: 211-215